<div id="readability-page-1"><p>Koninklijke Philips N.V. (NYSE:PHG - Get Free Report) has received an average rating of &#34;Moderate Buy&#34; from the five research firms that are presently  covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one  has issued  a strong buy recommendation on  the company.</p><div><p><span></span><span>Get <strong>Koninklijke Philips</strong> alerts:</span></p></div><p>Several equities analysts have recently issued reports on PHG shares. Wall Street Zen raised shares of Koninklijke Philips from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, November 22nd. Royal Bank Of Canada started coverage on shares of Koninklijke Philips in a research report on Wednesday. They issued a &#34;sector perform&#34; rating on the stock. Finally, Weiss Ratings  reissued a &#34;hold (c-)&#34; rating on shares of Koninklijke Philips in a research report on Monday.</p><p><b>View Our Latest Stock Analysis on PHG</b></p><h2>Koninklijke Philips Trading Down 1.0%</h2><p>NYSE PHG traded down $0.27 during trading hours on Wednesday, hitting $26.26. 199,540 shares of the company's stock were exchanged, compared to its average volume of 906,743. The firm has a market cap of $25.29 billion, a price-to-earnings ratio of 131.31, a PEG ratio of 0.71 and a beta of 0.79. The stock has a 50-day simple moving average of $27.81 and a 200 day simple moving average of $26.56. The company has a current ratio of 1.32, a quick ratio of 0.86 and a debt-to-equity ratio of 0.68. Koninklijke Philips has a 1-year low of $21.48 and a 1-year high of $29.54. </p><p>Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its earnings results on Tuesday, November 4th. The technology company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37. The business had revenue of $5.05 billion for the quarter, compared to analyst estimates of $4.30 billion. Koninklijke Philips had a net margin of 1.07% and a return on equity of 12.14%.  On average, equities analysts forecast that  Koninklijke Philips will post 1.63 EPS for the current fiscal year. </p><h2>Hedge Funds Weigh In On Koninklijke Philips</h2><p>Hedge funds have recently bought and sold shares of the company. First Affirmative Financial Network grew its position in  Koninklijke Philips by 5.1% during the third quarter. First Affirmative Financial Network now owns 11,418 shares of the technology company's stock valued at $311,000 after acquiring an additional 550 shares during the last quarter.  Coldstream Capital Management Inc. purchased a new stake in shares of  Koninklijke Philips in the 3rd quarter valued at $401,000.  Morningstar Investment Management LLC bought a new position in shares of  Koninklijke Philips during the 3rd quarter valued at $5,434,000.  XTX Topco Ltd grew its holdings in shares of  Koninklijke Philips by 6.2% during the 3rd quarter. XTX Topco Ltd now owns 31,246 shares of the technology company's stock valued at $852,000 after purchasing an additional 1,825 shares during the last quarter.  Finally, United Capital Financial Advisors LLC purchased a new position in  Koninklijke Philips in the 3rd quarter worth $213,000. Hedge funds and other institutional investors own  13.67% of the company's stock. </p><h2>About Koninklijke Philips</h2> (Get Free Report)<p>Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis &amp; Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Koninklijke Philips</li><li>Canadian Penny Stocks: Can They Make You Rich? </li><li>4 Quantum Stocks to Watch as the Next Computing Revolution Unfolds</li><li>How to buy stock: A step-by-step guide for beginners </li><li>Massive Breakout in Industrials: 3 Must-Watch Stocks Now</li><li>How the NYSE and NASDAQ are Different, Why That Matters to Investors</li><li>3 Tech Stocks Down Over 60%—Which One Is Worth Buying?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBIRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBIRw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Koninklijke Philips Right Now?</h2><p>Before you consider Koninklijke Philips, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.</p><p>While Koninklijke Philips currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Koninklijke Philips N.V. (NYSE:PHG) has received an average "Moderate Buy" rating from five research firms. Analysts' ratings include two holds, two buys, and one strong buy. Recent reports show varied opinions, with Wall Street Zen upgrading to "buy" and Royal Bank Of Canada rating "sector perform." The stock traded down 1.0% to $26.26, with a market cap of $25.29 billion. Hedge funds have adjusted their positions, owning 13.67% of the stock. Philips operates in health technology across various segments globally.</p>

Koninklijke Philips N.V. (NYSE:PHG) Given Average Recommendation of "Moderate Buy" by Brokerages